Skip to main content
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1984 Jun;65(3):337–346.

Late-stage cutaneous leishmaniasis: immunopathology of tuberculoid lesions in skin and lymph nodes.

D S Ridley, M J Ridley
PMCID: PMC2040969  PMID: 6378242

Abstract

Strong development of tuberculoid features in the late stage of cutaneous leishmaniasis presents immunopathological, diagnostic and sometimes therapeutic problems. Only two such cases were identified out of 30 late-stage cases of the disease. They were delineated on histological and immunocytological grounds, and found to present higher levels of Leishmania antigen and lower levels of IgG than the weakly tuberculoid cases. One case showed histological and skin test evidence of delayed-type hypersensitivity; the other case (clinically of the relapsing or recidiva variety) lacked such evidence. Here the residual antigen was segregated at the periphery of the lesion. In three late-stage cases for which lymph node biopsies were available there was a stronger tuberculoid response in lymph node or lymphatic than in the skin lesion. In two cases there was caseation. Germinal follicles were notably active. It is suggested that in cutaneous leishmaniasis a strong tuberculoid response may be associated not so much with immune complex formation (as in the majority of lesions) but with sequestration of antigen at a peripheral site or in the lymphatic apparatus.

Full text

PDF
337

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjune G., Barnetson R. S., Ridley D. S., Kronvall G. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol. 1976 Jul;25(1):85–94. [PMC free article] [PubMed] [Google Scholar]
  2. Lefford M. J. Lepromin as an indicator and inducer of protective immunity. Lepr Rev. 1981 Dec;52 (Suppl 1):221–229. doi: 10.5935/0305-7518.19810072. [DOI] [PubMed] [Google Scholar]
  3. Lew D. P., Perrin L. H., Vassalli J. D., Suter S., Lambert P. H., Waldvogel F. A. High levels of complement breakdown products in tuberculous pleural effusions. Clin Exp Immunol. 1983 Jun;52(3):569–574. [PMC free article] [PubMed] [Google Scholar]
  4. Poulter L. W., Pandolph C. R. Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection. Clin Exp Immunol. 1982 May;48(2):396–402. [PMC free article] [PubMed] [Google Scholar]
  5. Ridley D. S., Marsden P. D., Cuba C. C., Barreto A. C. A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans R Soc Trop Med Hyg. 1980;74(4):508–514. doi: 10.1016/0035-9203(80)90068-1. [DOI] [PubMed] [Google Scholar]
  6. Ridley M. J., Ridley D. S. Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase. Br J Exp Pathol. 1984 Jun;65(3):327–336. [PMC free article] [PubMed] [Google Scholar]
  7. Rook G. A. Three forms of delayed skin-test response evoked by mycobacteria. Nature. 1978 Jan 5;271(5640):64–65. doi: 10.1038/271064a0. [DOI] [PubMed] [Google Scholar]
  8. Schewach-Millet M., Fisher B. K., Semah D. Leishmaniasis recidivans treated with sodium stibogluconate. Cutis. 1981 Jul;28(1):67-8, 77, 84 passim. [PubMed] [Google Scholar]
  9. Turk J. L. Granuloma formation in lymph nodes. Proc R Soc Med. 1971 Sep;64(9):942–944. doi: 10.1177/003591577106400929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Witztum E., Spira D. T., Zuckerman A. Blast transformation in different stages of cutaneous leishmaniasis. Isr J Med Sci. 1978 Feb;14(2):244–247. [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES